Inventor
JUNGHEIM LOUIS NICKOLAUS
US17 patents
⚠️ This page may combine multiple inventors who share the name “JUNGHEIM LOUIS NICKOLAUS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LILLY CO ELI
12 patentsUS5891874AApr 6, 1999
Anti-viral compound
LILLY CO ELI163 citations96
US7320994B2Jan 22, 2008
Triazole derivatives as tachykinin receptor antagonists
LILLY CO ELI28 citations90
US7179804B2Feb 20, 2007
Tachykinin receptor antagonists
LILLY CO ELI30 citations90
US6653281B1Nov 25, 2003
Ring modified cyclic peptide analogs
LILLY CO ELI16 citations88
US5821242AOct 13, 1998
Anti-viral compounds
LILLY CO ELI12 citations71
US6114327ASep 5, 2000
Anti-viral compounds
LILLY CO ELI9 citations67
US6743794B2Jun 1, 2004
Methods and compounds for inhibiting MRP1
LILLY CO ELI7 citations58
US7037921B2May 2, 2006
Compounds and methods for inhibiting MRP1
LILLY CO ELI0 citations51
US6992097B2Jan 31, 2006
Growth hormone secretagogues
LILLY CO ELI1 citations48
US6939946B2Sep 6, 2005
Ring modified cyclic peptide analogs
LILLY CO ELI0 citations48
US7101891B2Sep 5, 2006
Compounds and pharmaceutical compositions for inhibiting MRP1
LILLY CO ELI0 citations41
US7125840B2Oct 24, 2006
Substituted dipeptides as growth hormone secretagogues
LILLY CO ELI0 citations40
EMISPHERE TECH INC
2 patentsUS7662771B2Feb 16, 2010
Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP)-1 compound or a melanocortin-4 receptor (MC4) agonist peptide
EMISPHERE TECH INC7 citations71
US7947841B2May 24, 2011
Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP)-1 compound or a melanocortin-4 receptor (MC4) agonist peptide
EMISPHERE TECH INC2 citations58